Contract Manufacturing
Inibsa's constant pursuit of excellence, along with an investment policy aimed at providing the highest technological standards, means we can offer our clients a wide range of services.
Laboratorios Inibsa is a pharmaceutical company with over 60 years of experience. A part of the Inibsa Group, the company provides products and services to the group companies, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through its contract manufacturing division.
Laboratorios Inibsa is a pharmaceutical company with over 60 years of experience. A part of the Inibsa Group, the company provides products and services to the group companies, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through its contract manufacturing division.
Currently we are working for companies in more than 50 countries worldwide from our facilities in Lliçà de Vall, 20km from Barcelona, Spain.
Our commitment to quality and service involves meeting the highest quality and regulatory standards, using the most advanced production technology available and having a team that is committed to achieving our objectives. All this makes Inibsa Group a competitive, sustainable, committed company that is focused on innovation and international expansion.
Laboratorios Inibsa can provide contract manufacturing services for a range of pharmaceutical product types.
We produce two types of injectable solutions: 1.8ml injectable cartridges and injectable glass ampoules in sizes from 2ml up to 10ml. Our production capacity for these is 150m units per year and 20m units per year respectively.
The company can also manufacture solid form hard capsules with a capacity of 80m units per year. Other products include oral liquid form glass ampoules, medical devices, antiseptics (up to 0.5m units per year) and clinical disinfectants (up to 2.5m units per year).
Pilot batch manufacturing services are available upon request.
Laboratorios Inibsa uses machinery of the highest quality to ensure the best possible products. Our equipment includes:
Our highly-qualified pharmaceutical development team can provide the following services:
A highly-qualified team of personnel and the most demanding certifications and calibrations mean we can carry out physical-chemical and microbiological studies, and analysis of raw materials, semi-produced products and finished products in compliance with Good Laboratory Practice (GLP) and pharmacopoeia (USP, EP).
We manage all the documentation required to comply with regulations, as well as obtaining the licences necessary to manufacture and market drugs, medical devices and nutritional products. Risk management, operational excellence and scientific knowledge are the pillars of our quality system.
At Inibsa we apply best practices and the latest healthcare quality management standards (EU GMP, ICH Q8, Q9, Q10, GAMP 5, Lean), and quality assurance is an integral part of our operations.
Products manufactured by Laboratorios Inibsa meet the highest quality standards to ensure customer satisfaction and patient safety. We have several quality integrated systems:
Laboratorios Inibsa has several primary and secondary packaging lines with a multitude of formats, which are sealed with DataMatrix for better product traceability:
Our contract engineering services include:
We have more than 5,000 places for raw materials, packaging materials, APIs, semi-produced products, finished products and returns, including:
Inibsa's constant pursuit of excellence, along with an investment policy aimed at providing the highest technological standards, means we can offer our clients a wide range of services.
Laboratorios Inibsa has obtained authorisation from the Spanish Health Ministry for its new capsule filling facilities, in accordance with EU-GMP (good manufacturing practices).
12 December 2013CDM Lavoisier has chosen Laboratorios Inibsa as the best option for the pharmaceutical injectable manufacturing. After several months of negotiations both Pharmaceutical Companies have signed a long-term contract for injectable ampoules for the French market.
14 October 2013Laboratorios Inibsa Laboratories, a pharmaceutical company with over 60 years of experience in pharmaceutical market, has reached an agreement with Accord Healthcare for the purchase of two dossiers of Mepivacaine for manufacturing and distribution in Italy, France, Germany, Denmark, Belgium, Austria and Sweden.
7 February 2013Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology